NCT02514746View on ClinicalTrials.gov

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

PHASE4CompletedINTERVENTIONAL

Enrollment

561

Participants

Timeline

Start Date

July 30, 2015

Primary Completion Date

December 15, 2016

Study Completion Date

January 12, 2017

Conditions

Encephalitis, Japanese

Interventions

BIOLOGICAL

Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine

0.5 mL subcutaneous injection

All Listed Sponsors

collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

PATH

OTHER

NCT02514746 - Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose | Biotech Hunter | Biotech Hunter